{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:28:08Z","timestamp":1793899688120,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft","award":["EN343\/16-1"],"award-info":[{"award-number":["EN343\/16-1"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Deutsche Forschungsgemeinschaft","award":["EN343\/18-1"],"award-info":[{"award-number":["EN343\/18-1"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC-2049-390688087"],"award-info":[{"award-number":["EXC-2049-390688087"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 295-424778381"],"award-info":[{"award-number":["TRR 295-424778381"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["522473931"],"award-info":[{"award-number":["522473931"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["394046635"],"award-info":[{"award-number":["394046635"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CA2816\/1-1"],"award-info":[{"award-number":["CA2816\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["01EJ2204A"],"award-info":[{"award-number":["01EJ2204A"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","award":["FKZ81X2100285"],"award-info":[{"award-number":["FKZ81X2100285"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["17CVD03"],"award-info":[{"award-number":["17CVD03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","award":["GSC203"],"award-info":[{"award-number":["GSC203"]}],"id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018707","name":"HORIZON EUROPE Reforming and enhancing the European Research and Innovation system","doi-asserted-by":"publisher","award":["733006"],"award-info":[{"award-number":["733006"]}],"id":[{"id":"10.13039\/100018707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018707","name":"HORIZON EUROPE Reforming and enhancing the European Research and Innovation system","doi-asserted-by":"publisher","award":["101095635"],"award-info":[{"award-number":["101095635"]}],"id":[{"id":"10.13039\/100018707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018707","name":"HORIZON EUROPE Reforming and enhancing the European Research and Innovation system","doi-asserted-by":"publisher","award":["779293"],"award-info":[{"award-number":["779293"]}],"id":[{"id":"10.13039\/100018707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018707","name":"HORIZON EUROPE Reforming and enhancing the European Research and Innovation system","doi-asserted-by":"publisher","award":["754995"],"award-info":[{"award-number":["754995"]}],"id":[{"id":"10.13039\/100018707","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","id":[{"id":"https:\/\/ror.org\/001w7jn25","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>G protein-coupled receptor (GPCR) directed regulatory autoantibodies (RABs) have previously been linked to poor functional outcome after ischemic stroke. We investigated the impact of anti-\u03b11\/\u03b12\/\u03b21\/\u03b22 receptor, endothelin B receptor, angiotensin II receptor type 2, and CXCR3 receptor directed RABs on functional outcome and recurrent events after ischemic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were derived from the Prospective Cohort with Incident Stroke Berlin (PROSCIS-B; NCT01363856). RABs were measured by ELISA (CellTrend) from sera collected within seven days of first-ever stroke. High RAB levels (quartile [Q]4 vs. Q1-3) and low levels (Q1 vs. Q2-4) were compared to reference groups. Quartile subgroups were characterized at baseline. Functional outcome, measured by the Modified Rankin Scale (mRS) at one year, was evaluated with ordinal logistic regression. Cox proportional hazard models were used to assess risk for a combined endpoint (stroke, myocardial infarction, death) over three years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>562 patients were included (mean age 67 (SD= 13); 38% female). All RABs showed more large artery atherosclerosis (LAA) stroke in Q1, while cardioembolic strokes (CE) were more frequent in Q4. Worse functional outcome at 12\u00a0months was associated with high levels (Q4) of alpha2-antibodies (abs) (OR=1.49; 95%CI=1.02\u20132.18) and ETB-abs (OR=1.49; 95%CI=1.02\u20132.18) vs. Q1-Q3. Recurrent cardiovascular risk over three years was higher with low levels (Q1) of AT2-abs (HR=1.86; 95%CI=1.22\u20132.86), alpha2-abs (HR=1.77; 95%CI=1.15\u20132.72), and beta1-abs (HR=1.58; 95%CI=1.03\u20132.44) vs. Q2-Q4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Differential associations of low vs. high levels of several RABs with stroke etiology, functional outcome, and recurrent vascular risk suggest potential roles in stroke pathophysiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-14103-6","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:26:48Z","timestamp":1788895608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoantibodies targeting G protein-coupled receptors and clinical outcome after ischemic stroke (PROSCIS-B)"],"prefix":"10.1007","volume":"273","author":[{"given":"Anna-Sophia","family":"Miesenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike A.","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Kosch\u00fctzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimrapat","family":"Gebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schulze-Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusan Ali","family":"Catar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kufner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Liman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-2374","authenticated-orcid":false,"given":"Pia S.","family":"Sperber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"1","key":"14103_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCRESAHA.124.323067","volume":"135","author":"S Liu","year":"2024","unstructured":"Liu S, Anderson PJ, Rajagopal S, Lefkowitz RJ, Rockman HA (2024) G protein-coupled receptors: a century of research and discovery. Circ Res 135(1):174\u2013197. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323067","journal-title":"Circ Res"},{"issue":"9","key":"14103_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103855","volume":"24","author":"O Cabral-Marques","year":"2025","unstructured":"Cabral-Marques O, Schimke LF, Moll G, Filgueiras IS, Nobile AL, Adri AS et al (2025) Advancing research on regulatory autoantibodies targeting GPCRs: insights from the 5th international symposium. Autoimmun Rev 24(9):103855. https:\/\/doi.org\/10.1016\/j.autrev.2025.103855","journal-title":"Autoimmun Rev"},{"issue":"5","key":"14103_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103310","volume":"22","author":"O Cabral-Marques","year":"2023","unstructured":"Cabral-Marques O, Moll G, Catar R, Preuss B, Bankamp L, Pecher AC et al (2023) Autoantibodies targeting G protein-coupled receptors: an evolving history in autoimmunity. Report of the 4th international symposium. Autoimmun Rev 22(5):103310. https:\/\/doi.org\/10.1016\/j.autrev.2023.103310","journal-title":"Autoimmun Rev"},{"issue":"3","key":"14103_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","volume":"36","author":"G Wallukat","year":"2014","unstructured":"Wallukat G, Schimke I (2014) Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases. Semin Immunopathol 36(3):351\u2013363. https:\/\/doi.org\/10.1007\/s00281-014-0425-9","journal-title":"Semin Immunopathol"},{"issue":"47","key":"14103_CR5","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1093\/eurheartj\/ehad666","volume":"44","author":"FS Muller","year":"2023","unstructured":"Muller FS, Aherrahrou Z, Grasshoff H, Heidorn MW, Humrich JY, Johanson L et al (2023) Autoantibodies against the chemokine receptor 3 predict cardiovascular risk. Eur Heart J 44(47):4935\u20134949. https:\/\/doi.org\/10.1093\/eurheartj\/ehad666","journal-title":"Eur Heart J"},{"issue":"11","key":"14103_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003742","volume":"3","author":"K Wenzel","year":"2008","unstructured":"Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V et al (2008) Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS ONE 3(11):e3742. https:\/\/doi.org\/10.1371\/journal.pone.0003742","journal-title":"PLoS ONE"},{"issue":"24","key":"14103_CR7","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1042\/CS20171305","volume":"131","author":"G Li","year":"2017","unstructured":"Li G, Cao Z, Wu XW, Wu HK, Ma Y, Wu B et al (2017) Autoantibodies against AT(1) and alpha(1)-adrenergic receptors predict arterial stiffness progression in normotensive subjects over a 5\u00a0year period. Clin Sci (Lond) 131(24):2947\u20132957. https:\/\/doi.org\/10.1042\/CS20171305","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"14103_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/HYPERTENSIONAHA.115.05428","volume":"66","author":"C Liles","year":"2015","unstructured":"Liles C, Li H, Veitla V, Liles JT, Murphy TA, Cunningham MW et al (2015) AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction. Hypertension 66(4):830\u2013835. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05428","journal-title":"Hypertension"},{"issue":"6","key":"14103_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R et al (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352(6):558\u2013569. https:\/\/doi.org\/10.1056\/NEJMoa035717","journal-title":"N Engl J Med"},{"issue":"2","key":"14103_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/ar4503","volume":"16","author":"J Gunther","year":"2014","unstructured":"Gunther J, Kill A, Becker MO, Heidecke H, Rademacher J, Siegert E et al (2014) Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients. Arthritis Res Ther 16(2):R65. https:\/\/doi.org\/10.1186\/ar4503","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"14103_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11926-015-0505-4","volume":"17","author":"A Kill","year":"2015","unstructured":"Kill A, Riemekasten G (2015) Functional autoantibodies in systemic sclerosis pathogenesis. Curr Rheumatol Rep 17(5):34. https:\/\/doi.org\/10.1007\/s11926-015-0505-4","journal-title":"Curr Rheumatol Rep"},{"key":"14103_CR12","doi-asserted-by":"publisher","first-page":"1289744","DOI":"10.3389\/fimmu.2023.1289744","volume":"14","author":"G Moll","year":"2023","unstructured":"Moll G, Luecht C, Gyamfi MA, da Fonseca DLM, Wang P, Zhao H et al (2023) Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-alpha signaling. Front Immunol 14:1289744. https:\/\/doi.org\/10.3389\/fimmu.2023.1289744","journal-title":"Front Immunol"},{"key":"14103_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.564526","volume":"11","author":"G Riemekasten","year":"2020","unstructured":"Riemekasten G, Petersen F, Heidecke H (2020) What makes antibodies against g protein-coupled receptors so special? a novel concept to understand chronic diseases. Front Immunol 11:564526. https:\/\/doi.org\/10.3389\/fimmu.2020.564526","journal-title":"Front Immunol"},{"issue":"1","key":"14103_CR14","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","volume":"9","author":"O Cabral-Marques","year":"2018","unstructured":"Cabral-Marques O, Marques A, Giil LM, De Vito R, Rademacher J, Gunther J et al (2018) GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat Commun 9(1):5224. https:\/\/doi.org\/10.1038\/s41467-018-07598-9","journal-title":"Nat Commun"},{"issue":"6","key":"14103_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/cvr\/10.6.613","volume":"10","author":"L Sterin-Borda","year":"1976","unstructured":"Sterin-Borda L, Cossio PM, Gimeno MF, Gimeno AL, Diez C, Laguens RP et al (1976) Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and function aspects. Cardiovasc Res 10(6):613\u2013622. https:\/\/doi.org\/10.1093\/cvr\/10.6.613","journal-title":"Cardiovasc Res"},{"issue":"3","key":"14103_CR16","first-page":"679","volume":"57","author":"E Borda","year":"1984","unstructured":"Borda E, Pascual J, Cossio P, De La Vega M, Arana R, Sterin-Borda L (1984) A circulating IgG in Chagas\u2019 disease which binds to beta-adrenoceptors of myocardium and modulates their activity. Clin Exp Immunol 57(3):679\u2013686","journal-title":"Clin Exp Immunol"},{"issue":"8938","key":"14103_CR17","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/s0140-6736(94)90456-1","volume":"344","author":"ML Fu","year":"1994","unstructured":"Fu ML, Herlitz H, Wallukat G, Hilme E, Hedner T, Hoebeke J et al (1994) Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet 344(8938):1660\u20131663. https:\/\/doi.org\/10.1016\/s0140-6736(94)90456-1","journal-title":"Lancet"},{"issue":"2","key":"14103_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.hyp.29.2.678","volume":"29","author":"HP Luther","year":"1997","unstructured":"Luther HP, Homuth V, Wallukat G (1997) Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 29(2):678\u2013682. https:\/\/doi.org\/10.1161\/01.hyp.29.2.678","journal-title":"Hypertension"},{"issue":"4","key":"14103_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/0735-1097(95)00262-2","volume":"26","author":"PA Chiale","year":"1995","unstructured":"Chiale PA, Rosenbaum MB, Elizari MV, Hjalmarson A, Magnusson Y, Wallukat G et al (1995) High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol 26(4):864\u2013869. https:\/\/doi.org\/10.1016\/0735-1097(95)00262-2","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"14103_CR20","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1253\/circj.cj-11-1374","volume":"76","author":"D Brisinda","year":"2012","unstructured":"Brisinda D, Sorbo AR, Venuti A, Ruggieri MP, Manna R, Fenici P et al (2012) Anti-beta-adrenoceptors autoimmunity causing \u201cidiopathic\u201d arrhythmias and cardiomyopathy. Circ J 76(6):1345\u20131353. https:\/\/doi.org\/10.1253\/circj.cj-11-1374","journal-title":"Circ J"},{"issue":"2","key":"14103_CR21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ehf2.14293","volume":"10","author":"E Zweck","year":"2023","unstructured":"Zweck E, Karschnia M, Scheiber D, Heidecke H, Dechend R, Barthuber C et al (2023) Receptor autoantibodies: associations with cardiac markers, histology, and function in human non-ischaemic heart failure. ESC Heart Fail 10(2):1258\u20131269. https:\/\/doi.org\/10.1002\/ehf2.14293","journal-title":"ESC Heart Fail"},{"key":"14103_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fimmu.2018.00428","volume":"9","author":"A Recke","year":"2018","unstructured":"Recke A, Regensburger AK, Weigold F, Muller A, Heidecke H, Marschner G et al (2018) Autoantibodies in serum of systemic scleroderma patients: peptide-based epitope mapping indicates increased binding to cytoplasmic domains of cxcr3. Front Immunol 9:428. https:\/\/doi.org\/10.3389\/fimmu.2018.00428","journal-title":"Front Immunol"},{"key":"14103_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molimm.2020.12.027","volume":"131","author":"X Yue","year":"2021","unstructured":"Yue X, Deng F, Chen J, Yin J, Zheng J, Chen Y et al (2021) Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren\u2019s syndrome. Mol Immunol 131:112\u2013120. https:\/\/doi.org\/10.1016\/j.molimm.2020.12.027","journal-title":"Mol Immunol"},{"key":"14103_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.895501","volume":"13","author":"C Tabeling","year":"2022","unstructured":"Tabeling C, Gonzalez Calera CR, Lienau J, Hoppner J, Tschernig T, Kershaw O et al (2022) Endothelin B receptor immunodynamics in pulmonary arterial hypertension. Front Immunol 13:895501. https:\/\/doi.org\/10.3389\/fimmu.2022.895501","journal-title":"Front Immunol"},{"key":"14103_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981532","volume":"13","author":"F Sotzny","year":"2022","unstructured":"Sotzny F, Filgueiras IS, Kedor C, Freitag H, Wittke K, Bauer S et al (2022) Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front Immunol 13:981532. https:\/\/doi.org\/10.3389\/fimmu.2022.981532","journal-title":"Front Immunol"},{"issue":"1","key":"14103_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02833-2","volume":"19","author":"KJ Wirth","year":"2021","unstructured":"Wirth KJ, Scheibenbogen C (2021) Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). J Transl Med 19(1):162. https:\/\/doi.org\/10.1186\/s12967-021-02833-2","journal-title":"J Transl Med"},{"key":"14103_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00170","volume":"5","author":"D Ernst","year":"2018","unstructured":"Ernst D, Widera C, Weiberg D, Derlin T, Ahrenstorf G, Sogkas G et al (2018) Beta-1-adrenergic receptor antibodies in acute coronary syndrome: is less sometimes more? Front Cardiovasc Med 5:170. https:\/\/doi.org\/10.3389\/fcvm.2018.00170","journal-title":"Front Cardiovasc Med"},{"issue":"23","key":"14103_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032441","volume":"12","author":"TG Liman","year":"2023","unstructured":"Liman TG, Siegerink B, Piper S, Catar R, Moll G, Riemekasten G et al (2023) Vasoregulatory autoantibodies and clinical outcome after ischemic stroke-PROSCIS-B. J Am Heart Assoc 12(23):e032441. https:\/\/doi.org\/10.1161\/JAHA.123.032441","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"14103_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1747-4949.2012.00871.x","volume":"8","author":"TG Liman","year":"2013","unstructured":"Liman TG, Zietemann V, Wiedmann S, Jungehuelsing GJ, Endres M, Wollenweber FA et al (2013) Prediction of vascular risk after stroke - protocol and pilot data of the Prospective Cohort with Incident Stroke (PROSCIS). Int J Stroke 8(6):484\u2013490. https:\/\/doi.org\/10.1111\/j.1747-4949.2012.00871.x","journal-title":"Int J Stroke"},{"issue":"9","key":"14103_CR30","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1161\/STROKEAHA.118.022161","volume":"49","author":"V Feigin","year":"2018","unstructured":"Feigin V, Norrving B, Sudlow CLM, Sacco RL (2018) Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century. Stroke 49(9):2248\u20132255. https:\/\/doi.org\/10.1161\/STROKEAHA.118.022161","journal-title":"Stroke"},{"issue":"1","key":"14103_CR31","doi-asserted-by":"publisher","DOI":"10.4081\/ni.2013.e2","volume":"5","author":"K Savio","year":"2013","unstructured":"Savio K, Pietra GL, Oddone E, Reggiani M, Leone MA (2013) Reliability of the modified rankin scale applied by telephone. Neurol Int 5(1):e2. https:\/\/doi.org\/10.4081\/ni.2013.e2","journal-title":"Neurol Int"},{"issue":"2","key":"14103_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2007-993985","volume":"67","author":"K Berger","year":"1999","unstructured":"Berger K, Weltermann B, Kolominsky-Rabas P, Meves S, Heuschmann P, Bohner J et al (1999) The reliability of stroke scales the german version of NIHSS, ESS and rankin scales. Fortschr Neurol Psychiatr 67(2):81\u201393. https:\/\/doi.org\/10.1055\/s-2007-993985","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"2","key":"14103_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0891988708328214","volume":"22","author":"SE Cook","year":"2009","unstructured":"Cook SE, Marsiske M, McCoy KJ (2009) The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment. J Geriatr Psychiatry Neurol 22(2):103\u2013109. https:\/\/doi.org\/10.1177\/0891988708328214","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"14103_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000255464","volume":"34","author":"DS Knopman","year":"2010","unstructured":"Knopman DS, Roberts RO, Geda YE, Pankratz VS, Christianson TJ, Petersen RC et al (2010) Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia. Neuroepidemiology 34(1):34\u201342. https:\/\/doi.org\/10.1159\/000255464","journal-title":"Neuroepidemiology"},{"issue":"6","key":"14103_CR35","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.str.32.6.1318","volume":"32","author":"LO Wahlund","year":"2001","unstructured":"Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6):1318\u20131322. https:\/\/doi.org\/10.1161\/01.str.32.6.1318","journal-title":"Stroke"},{"issue":"6","key":"14103_CR36","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/ije\/dyw341","volume":"45","author":"J Textor","year":"2016","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT (2016) Robust causal inference using directed acyclic graphs: the R package \u201cdagitty.\u201d Int J Epidemiol 45(6):1887\u20131894. https:\/\/doi.org\/10.1093\/ije\/dyw341","journal-title":"Int J Epidemiol"},{"issue":"11","key":"14103_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jama.2022.1816","volume":"327","author":"AM Lipsky","year":"2022","unstructured":"Lipsky AM, Greenland S (2022) Causal directed acyclic graphs. JAMA 327(11):1083\u20131084. https:\/\/doi.org\/10.1001\/jama.2022.1816","journal-title":"JAMA"},{"issue":"3","key":"14103_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/cc10240","volume":"15","author":"B Roozenbeek","year":"2011","unstructured":"Roozenbeek B, Lingsma HF, Perel P, Edwards P, Roberts I, Murray GD et al (2011) The added value of ordinal analysis in clinical trials: an example in traumatic brain injury. Crit Care 15(3):R127. https:\/\/doi.org\/10.1186\/cc10240","journal-title":"Crit Care"},{"issue":"2","key":"14103_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"2018","unstructured":"Cox DR (2018) Regression models and life-tables. J Roy Stat Soc: Ser B (Methodol) 34(2):187\u2013202. https:\/\/doi.org\/10.1111\/j.2517-6161.1972.tb00899.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"3","key":"14103_CR40","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00415-022-11481-5","volume":"270","author":"HF Ali","year":"2023","unstructured":"Ali HF, Fast L, Khalil A, Siebert E, Liman T, Endres M et al (2023) White matter hyperintensities are an independent predictor of cognitive decline 3 years following first-ever stroke-results from the PROSCIS-B study. J Neurol 270(3):1637\u20131646. https:\/\/doi.org\/10.1007\/s00415-022-11481-5","journal-title":"J Neurol"},{"issue":"1","key":"14103_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","volume":"24","author":"HP Adams Jr.","year":"1993","unstructured":"Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24(1):35\u201341. https:\/\/doi.org\/10.1161\/01.str.24.1.35","journal-title":"Stroke"},{"issue":"1","key":"14103_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51125-9","volume":"9","author":"D Ernst","year":"2019","unstructured":"Ernst D, Westerbergh J, Sogkas G, Jablonka A, Ahrenstorf G, Schmidt RE et al (2019) Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome. Sci Rep 9(1):14552. https:\/\/doi.org\/10.1038\/s41598-019-51125-9","journal-title":"Sci Rep"},{"issue":"23","key":"14103_CR43","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","volume":"378","author":"P Amarenco","year":"2018","unstructured":"Amarenco P, Lavallee PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H et al (2018) Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med 378(23):2182\u20132190. https:\/\/doi.org\/10.1056\/NEJMoa1802712","journal-title":"N Engl J Med"},{"key":"14103_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fphys.2020.00076","volume":"11","author":"L Shang","year":"2020","unstructured":"Shang L, Zhang L, Shao M, Feng M, Shi J, Dong Z et al (2020) Elevated beta1-adrenergic receptor autoantibody levels increase atrial fibrillation susceptibility by promoting atrial fibrosis. Front Physiol 11:76. https:\/\/doi.org\/10.3389\/fphys.2020.00076","journal-title":"Front Physiol"},{"issue":"1","key":"14103_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006155","volume":"13","author":"HD Dungen","year":"2020","unstructured":"Dungen HD, Dordevic A, Felix SB, Pieske B, Voors AA, McMurray JJV et al (2020) Beta(1)-adrenoreceptor autoantibodies in heart failure: physiology and therapeutic implications. Circ Heart Fail 13(1):e006155. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006155","journal-title":"Circ Heart Fail"},{"issue":"1","key":"14103_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/a-2178-6491","volume":"44","author":"WC Schrottmaier","year":"2024","unstructured":"Schrottmaier WC, Assinger A (2024) The concept of thromboinflammation. Hamostaseologie 44(1):21\u201330. https:\/\/doi.org\/10.1055\/a-2178-6491","journal-title":"Hamostaseologie"},{"issue":"24","key":"14103_CR47","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.120.049768","volume":"142","author":"AH Katsanos","year":"2020","unstructured":"Katsanos AH, Kamel H, Healey JS, Hart RG (2020) Stroke prevention in atrial fibrillation: looking forward. Circulation 142(24):2371\u20132388. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049768","journal-title":"Circulation"},{"issue":"10","key":"14103_CR48","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1007\/s00415-022-11203-x","volume":"269","author":"PS Sperber","year":"2022","unstructured":"Sperber PS, Gebert P, Broersen LHA, Huo S, Piper SK, Teegen B et al (2022) Serum anti-NMDA-receptor antibodies and cognitive function after ischemic stroke (PROSCIS-B). J Neurol 269(10):5521\u20135530. https:\/\/doi.org\/10.1007\/s00415-022-11203-x","journal-title":"J Neurol"},{"key":"14103_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02744-w","author":"FA Arlt","year":"2024","unstructured":"Arlt FA, Sperber PS, von Rennenberg R, Gebert P, Teegen B, Georgakis MK et al (2024) Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after stroke. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-024-02744-w","journal-title":"Mol Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14103-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14103-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14103-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:03:51Z","timestamp":1793898231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14103-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14103"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14103-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ME reports grants from Bayer and Ipsen and fees paid to the Charit\u00e9 from Amgen, AstraZeneca, Bayer, BMS, Daiichi Sankyo; all outside the submitted work. CH serves Pantherna Therapeutics GmbH as a member of the Scientific Advisory Board. HH and KSF: HH and KSF are the CEOs and stakeholders at CellTrend GmbH. All other authors have nothing to disclose in relation to this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"581"}}